0253-9780
2016 Issue 5
..............page:381-383
Low-dose and high-dose 131I therapy for low and intermediate risk differentiated thyroid cancer: a randomized controlled clinical study
zuo yuan ;, huang zuo ;, dong ping ;, pan ming zhi ;, li lin ;, zhu jing qiang ;, gong ri xiang ;, li zhi hui ;, wei tao ;
zuo yuan ;, huang zuo ;, dong ping ;, pan ming zhi ;, li lin ;, zhu jing qiang ;, gong ri xiang ;, li zhi hui ;, wei tao ;
..............page:384-388
Change of pre-ablative thyroid-stimulating hormone after thyroid hormone withdrawal and its response to 131I therapy in patients with low to intermediate risk differentiated thyroid cancer
Li Xin;,Zhao Teng;,Gao Wen;,Li Hui;,Wang Chen;,Lin Yansong;
Li Xin;,Zhao Teng;,Gao Wen;,Li Hui;,Wang Chen;,Lin Yansong;
..............page:389-393
Correlation between external dose equivalent rate and residual radioactivity in patients with differentiated thyroid carcinoma after 131I therapy
Wang Renfei;,Tan Jian;,Zhang Guizhi;,He Yajing;
Wang Renfei;,Tan Jian;,Zhang Guizhi;,He Yajing;
..............page:394-397
Protective effect of vitamin E to the function of salivary glands in postsurgical patients with differentiated thyroid carcinoma after first 131I ablative therapy
wang peng ;, meng zhao wei ;, tan jian ;, zhang gui zhi ;, li xue ;, liu na ;, hu tian peng ;,arun upadhyaya;
wang peng ;, meng zhao wei ;, tan jian ;, zhang gui zhi ;, li xue ;, liu na ;, hu tian peng ;,arun upadhyaya;
..............page:398-401
Utility of 18F-FDG PET/CT for the diagnosis and staging of gallbladder carcinoma
wang zhen ;, wu hu bing ;, wang quan shi ;, wang li juan ;, zhou wen lan ;, li hong sheng ;, dong zuo ;, tian ying ;
wang zhen ;, wu hu bing ;, wang quan shi ;, wang li juan ;, zhou wen lan ;, li hong sheng ;, dong zuo ;, tian ying ;
..............page:402-407
Prognostic value of metabolic tumor volume on 18F-FDG PET/CT imaging in patients with pancreatic cancer
Wu Peng;,Yu Lijuan;,Li Xueyan;
Wu Peng;,Yu Lijuan;,Li Xueyan;
..............page:408-412
Analysis of relevant factors influencing 18F-FDG uptake in primary lesion of breast invasive ductal carcinoma
Xu Qiaoling;,You Xuyang;,Yu Chunjing;,Wu Najing;,Wan Weixing;
Xu Qiaoling;,You Xuyang;,Yu Chunjing;,Wu Najing;,Wan Weixing;
..............page:413-419
..............page:419,425,435,449,469,478,480
Prognostic value of △SUV and Deauville 5-point scoring in patients with diffuse large B-cell lymphoma
Gao Yan;,Zhao Jinhua;,Song Jianhua;,Chen Xiang;,Liu Changcun;,Sun Yiwen;
Gao Yan;,Zhao Jinhua;,Song Jianhua;,Chen Xiang;,Liu Changcun;,Sun Yiwen;
..............page:420-425
Accuracy of 99Tcm-rituximab sentinel lymph node biopsy in staging of cutaneous malignant melanoma patients and its relationship with survival
li zuo ;, lin bao he ;, fan yang ;, chen pu zuo ;, zhao qi chao ;, wang xue juan ;, di shi zuo ;, zhu hua ;, yang zhi ;
li zuo ;, lin bao he ;, fan yang ;, chen pu zuo ;, zhao qi chao ;, wang xue juan ;, di shi zuo ;, zhu hua ;, yang zhi ;
..............page:426-430
Diagnostic value of dual-phase 99Tcm-MIBI scintigraphy in patients with ectopic secondary hyperparathyroidism
Xu Xiaofei;,Liu Yajie;,Zhang Weixiao;,Tang Bing;
Xu Xiaofei;,Liu Yajie;,Zhang Weixiao;,Tang Bing;
..............page:431-435
Incremental value of 99Tcm-MIBI SPECT/CT imaging on the preoperative diagnosis of primary hyperparathyroidism
Wu Shuting;,Zhu Xiaohua;,Zhang Guopeng;,Zhou Jian;,Hu Jian;,Xianyu Zhiqun;
Wu Shuting;,Zhu Xiaohua;,Zhang Guopeng;,Zhou Jian;,Hu Jian;,Xianyu Zhiqun;
..............page:436-440
Diagnostic value of a modified dynamic salivary gland scintigraphy for Sj(o)gren's syndrome
Chen Shuzhen;,Ma Hongxing;,Wang Chenghong;,Yang Yueli;,Wang Hengli;,Zhang Liping;
Chen Shuzhen;,Ma Hongxing;,Wang Chenghong;,Yang Yueli;,Wang Hengli;,Zhang Liping;
..............page:441-444
Optimal labeling conditions of 68Ga-DOTA-iNGR and its biodistribution in mice
Zhao Mingxuan;,Zhang Mingru;,Kang Fei;,Yang Weidong;,Wang Shengjun;,Ma Xiaowei;,Wang Jing;
Zhao Mingxuan;,Zhang Mingru;,Kang Fei;,Yang Weidong;,Wang Shengjun;,Ma Xiaowei;,Wang Jing;
..............page:445-449
Preparation of 99Tcm-MAG3-VEGF125-136 polypeptide and its biodistribution and imaging in osteosarcoma mice
Chen Min;,Liu Xiaomei;,Wei Lingge;,Fu Peng;,Guo Ainan;
Chen Min;,Liu Xiaomei;,Wei Lingge;,Fu Peng;,Guo Ainan;
..............page:450-453
The antioxidant effects of 99Tc-MDP on the brain of D-galactose induced aged mice
Xue Xiuqing;,Zheng Jian;,Wu Yiwei;
Xue Xiuqing;,Zheng Jian;,Wu Yiwei;
..............page:454-457
Clinical practice guideline of 18F-FDG PET/CT in lymphoma (2016 edition)
PET and Molecular Imaging Group of Chinese Society;
PET and Molecular Imaging Group of Chinese Society;
..............page:458-460
Design and application of information management system of nuclear medicine
Chen Song;,Li Yaming;,Han Chunqi;,Yue Kun;,Shao Wei;,Zeng Hui;
Chen Song;,Li Yaming;,Han Chunqi;,Yue Kun;,Shao Wei;,Zeng Hui;
..............page:461-463
Influence of different outlining for region of interest in one kidney with Gates method on glomerular filtration rate of the contralateral kidney
Wang Changyin;,Zhao Yanfen;
Wang Changyin;,Zhao Yanfen;
..............page:464-465
Influence of tube voltage in CT-induced DNA double-strand breaks in human peripheral blood lymphocytes
Zhang Bo;,Gong Jianping;,Zhang Wei;,Pan Shiwen;
Zhang Bo;,Gong Jianping;,Zhang Wei;,Pan Shiwen;
..............page:466-467
SPECT/CT imaging of a rare bone metastasis mimicking SAPHO syndrome
Ni Jianming;,Chao Lin;
Ni Jianming;,Chao Lin;
..............page:468-469
Radionuclide molecular probe for the diagnosis and target therapy of malignant melanoma
Feng Hongyan;,Lan Xiaoli;,Zhang Yongxue;
Feng Hongyan;,Lan Xiaoli;,Zhang Yongxue;
..............page:470-473
Application of ultrasensitive thyroglobulin assays in the follow-up of differentiated thyroid carcinoma
Wei Weijun;,Shen Chentian;,Song Hongjun;,Qiu Zhongling;,Luo Quanyong;
Wei Weijun;,Shen Chentian;,Song Hongjun;,Qiu Zhongling;,Luo Quanyong;
..............page:474-478
A brief report on the results of the national survey of nuclear medicine in 2016
Chinese Society of Nuclear Medicine;
Chinese Society of Nuclear Medicine;
..............page:479-480